SCHEMBL697020

SCHEMBL697020

Cc1ccc2c(N)nc(-c3ccccc3C)cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.46
CYP1A2 P05177 1/20 0.43
PTPN1 P18031 1/20 0.42
HPGD P15428 3/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
RAD52 P43351 1/20 0.41
MAP4K1 Q92918 4/20 0.41
ADORA2A P29274 2/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PKM P14618 1/20 0.38
HSP90AA1 P07900 1/20 0.38
ALOX15 P16050 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL509568 0.98 DHFR (0.44) DHFRCYP1A2PTPN1HPGDLMNA
SCHEMBL509116 0.88 DHFR (0.46) DHFRCYP1A2PTPN1HPGDLMNA
SCHEMBL11377936 0.85 DHFR (0.49) DHFRCYP1A2PTPN1HPGDALDH1A1
SCHEMBL10389070 0.85 DHFR (0.46) DHFRCYP1A2HPGDKDM4EALDH1A1
SCHEMBL510084 0.85 GRM2 (0.46) HPGDRAD52ADORA2AMEN1KMT2A
SCHEMBL509605 0.84 CYP1A2 (0.50) DHFRCYP1A2HPGDLMNAKDM4E
SCHEMBL509907 0.82 HSP90AA1 (0.56) DHFRPTPN1HPGDKDM4EALDH1A1
SCHEMBL509700 0.79 RAD52 (0.48) DHFRHPGDLMNAKDM4EALDH1A1
SCHEMBL509882 0.78 RAD52 (0.64) DHFRKDM4EGAARAD52MEN1
SCHEMBL509564 0.77 ADORA2A (0.47) CYP1A2HPGDLMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099765-B1 5, 6, OR 7-SUBSTITUTED-3-ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS REXAHN PHARMACEUTICALS INC (US) 2012-08-29 EP disclosed
EP-2423196-A1 5, 6 or 7-substituted-3-phenylisoquinolinamine derivatives and therapeutic use thereof Rexahn Pharmaceuticals, Inc. (US) 2012-02-29 EP disclosed